动脉瘤性蛛网膜下腔出血神经重症治疗结果与不良预后危险因素:两个年龄组的比较
该回顾性单中心研究纳入2014-2019年神经ICU收治的行动脉瘤治疗的患者,按年龄≥70岁与<70岁分组并按WFNS分级1:3匹配。结果显示年龄是预后的主要决定因素,急性脑积水和脑内出血仅与年轻患者的不良预后相关。
要点
- 年龄≥70岁是行动脉瘤治疗SAH患者预后不良的主要决定因素。
- 急性脑积水和脑内出血仅与年轻患者不良预后相关。
- WFNS I-III级年轻患者预后良好率91%,老年组仅52%。
核心结论
- 在积极行动的动脉瘤性SAH患者中,年龄是预后的主要决定因素。
- 反映颅内压升高的因素(急性脑积水和脑内出血)仅与年轻患者的不良预后相关。
研究设计与样本
- 回顾性单中心分析,纳入2014-2019年神经ICU收治的行动脉瘤治疗的动脉瘤性SAH患者。
- 老年组定义为≥70岁,年轻组<70岁;每例老年患者按相同WFNS分级匹配3例年轻患者。
- 共112例老年患者中95例(85%)和336例年轻患者中317例(94%)接受动脉瘤治疗。
主要发现
- 年轻组WFNS I-III级患者预后良好率91%,老年组为52%。
- WFNS IV-V级患者中,年轻组预后良好率51%,老年组为24%。
- 年轻患者中急性脑积水与不良预后相关(OR 4.7,95% CI 2.6-8.4),脑内出血与不良预后相关(OR 3.7,95% CI 2.1-6.4)。
- 老年患者中急性脑积水(OR 1.8,95% CI 0.8-4.2)和脑内出血(OR 1.3,95% CI 0.5-3.1)与不良预后无显著关联。
关键数值与推荐
- 预后良好定义为12个月时GOS 4-5分。
- 年龄分组界值为70岁。
- WFNS分级用于匹配。
临床怎么用
- 对行动脉瘤治疗的SAH患者,年龄≥70岁提示预后较差,应加强预期管理。
- 年轻患者出现急性脑积水或脑内出血时,应警惕不良预后风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The mean age of actively treated subarachnoid hemorrhage (SAH) patients is increasing. We aimed to compare outcomes and prognostic factors between older and younger SAH patients. METHODS: A retrospective single-center analysis of aneurysmal SAH patients admitted to a neuro-ICU during 2014-2019. We defined older patients as ≥70 years and younger patients as <70 years. For every older patient, we identified three younger patients with the same World Federation of Neurological Surgeons (WFNS) grade. We only included patients receiving active aneurysm treatment. Favorable functional outcome, defined as a Glasgow Outcome Scale (GOS) of 4-5 at 12 months, was our primary outcome. We used logistic regression to compare prognostic factors between the groups. RESULTS: Ninety-five (85%) of 112 older patients and 317 (94%) of 336 younger patients received aneurysm treatment. Of the younger patients, 91% with a good-grade SAH (WFNS I-III) had a favorable outcome compared to 52% in the older good-grade SAH group. In poor-grade patients (WFNS IV-V), favorable outcome was seen in 51% of younger patients, compared to 24% of older patients. Acute hydrocephalus and intracerebral hemorrhage were associated with unfavorable outcome in the younger (OR 4.7, 95% CI 2.6-8.4, and OR 3.7, 95% CI 2.1-6.4), but not in the older patients (OR 1.8, 95% CI 0.8-4.2, and OR 1.3, 95% CI 0.5-3.1, respectively). CONCLUSIONS: In actively treated SAH patients, age was a major determinant of outcome. Factors reflecting increases in intracranial pressure associated with outcome only among younger patients.
引用
- Välimäki V, Luostarinen T, Satopää J, et al. Neurointensive care results and risk factors for unfavorable outcome in aneurysmatic SAH: a comparison of two age groups. Acta Neurochir (Wien). 2021. PMID: 33515123. doi:10.1007/s00701-021-04731-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。